Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer (Q45141920)

10 December 2017

title

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer (English)

1 reference

10 December 2017

1 reference

1 reference

Gyeong Hoon Kang

13

0 references

Yung-Jue Bang

9

object named as

Yung-Jue Bang

1 reference

10 December 2017

8

Seock-Ah Im

1 reference

10 December 2017

7

Do-Youn Oh

1 reference

10 December 2017

1

Sae-Won Han

1 reference

10 December 2017

14

Tae-You Kim

1 reference

10 December 2017

5

Kyung-Hun Lee

1 reference

10 December 2017

10

Seung-Yong Jeong

1 reference

10 December 2017

12

Jae-Gahb Park

1 reference

10 December 2017

4

Nam-Yun Cho

1 reference

10 December 2017

Hyun-Jung Lee

2

1 reference

10 December 2017

Jeong Mo Bae

3

1 reference

10 December 2017

Tae-Yong Kim

6

1 reference

10 December 2017

Kyu Joo Park

11

1 reference

10 December 2017

language of work or name

English

0 references

publication date

29 October 2012

1 reference

International Journal of Cancer

10 December 2017

published in

1 reference

10 December 2017

volume

132

1 reference

10 December 2017

issue

9

1 reference

10 December 2017

page(s)

2209-2216

1 reference

10 December 2017

cites work

Global cancer statistics

1 reference

Worldwide variations in colorectal cancer

21 January 2018

1 reference

Nationwide cancer incidence in Korea, 2003-2005.

21 January 2018

1 reference

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

21 January 2018

1 reference

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

21 January 2018

1 reference

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

21 January 2018

1 reference

Molecular classification and correlates in colorectal cancer

21 January 2018

1 reference

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

The chromosomal instability pathway in colon cancer

21 January 2018

1 reference

Microsatellite instability in colorectal cancer

21 January 2018

1 reference

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

21 January 2018

1 reference

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers.

21 January 2018

1 reference

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

21 January 2018

1 reference

The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status

21 January 2018

1 reference

DNA methylation predicts recurrence from resected stage III proximal colon cancer

21 January 2018

1 reference

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

21 January 2018

1 reference

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

21 January 2018

1 reference

Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin

21 January 2018

1 reference

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

21 January 2018

1 reference

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

21 January 2018

1 reference

Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer

21 January 2018

1 reference

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample

21 January 2018

1 reference

Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms

21 January 2018

1 reference

Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases

21 January 2018

1 reference

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

21 January 2018

1 reference

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data

21 January 2018

1 reference

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

21 January 2018

1 reference

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27888

1 reference

10 December 2017

1 reference